Dataset from A Multicenter, Randomized, Open-label Clinical Study of S-649266 or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00009790
下载链接
链接失效反馈官方服务：
资源简介：
This study is designed to provide evidence of efficacy of cefiderocol in the treatment of
serious infections in adult patients caused by carbapenem-resistant Gram-negative pathogens.
创建时间：
2024-11-27
